Ronald van Vollenhoven, PhD

Articles by Ronald van Vollenhoven, PhD

Systemic Lupus Erythematosus Treatment Advances: Anifrolumab

ByFotios Koumpouras, MD, FACR,Ronald van Vollenhoven, PhD

March 18th 2022

The rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.

Latest Updated Articles

Systemic Lupus Erythematosus Treatment Advances: Anifrolumab
Published: March 18th 2022 | Updated: